Home
›
4D Molecular Therapeutics, Inc.
› SC 13G/A Feb 14, 2024
4D Molecular Therapeutics, Inc. (FDMT): SC 13G/A filed Feb 14, 2024
Form type
SC 13G/A
Filing date
Feb 14, 2024
Accession number
0001193125-24-036378
Filer
4D Molecular Therapeutics, Inc.
(CIK 1650648)